Short-term results of the pulmonary embolism treatment
Aim. Acute pulmonary embolism (PE) is a common and often fatal disease with the level of mortality in the acute phase from 7 to 11%. In order to develop indications to thrombolytic therapy the short-term results of treatment with the use of combination therapy were studied. This treatment included:...
Saved in:
| Main Authors: | A. S. Nikonenko, A. A. Nikonenko, S. A. Matvieiev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2015-08-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/50307/47679 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Analysis of Long-Term Results and Quality of Life in Patients with Massive Pulmonary Embolism in the Course of Treatment with Thrombolytic and Anticoagulant Drugs
by: A. G. Pronin
Published: (2019-11-01) -
THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM: AN EFFECT ON PULMONARY PERFUSION (PART 2)
by: O. V. Nikitina, et al.
Published: (2018-07-01) -
Long-Term Results of Surgical Treatment of Pulmonary Embolism (PE) by Balloon Angioplasty (BAP) in Combination with Thrombolytic Therapy
by: M. V. Davydenko, et al.
Published: (2019-01-01) -
Thrombolytic and Anticoagulant Therapy for Pulmonary Embolism with High and Intermendiate Risk of Early Death. Part 3. An Effect on Pulmonary Perfusion with High and Intermediate Risk of Early Death
by: O. V. Nikitina, et al.
Published: (2018-11-01) -
Clinical case of the non-immunogenic recombinant staphylokinase usage in the treatment of massive pulmonary embolism in patient with genetically determined thrombophilia
by: G. D. Azizova, et al.
Published: (2025-04-01)